House Commerce Cmte. Launches Inquiry Into FDA Single-Use, Reuse Regs
This article was originally published in The Gray Sheet
Executive SummaryHouse Commerce Committee members will decide whether to hold a hearing on FDA regulation of reprocessed single-use medical devices after they receive a response from FDA Commissioner Jane Henney to a Dec. 8 request for information.
You may also be interested in...
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.